LOS ANGELES, California, Feb. 14 -- Paul Hastings, a law firm, issued the following news:

* * *

Paul Hastings Advising Aardvark Therapeutics on Its IPO

Paul Hastings LLP is advising Aardvark Therapeutics, Inc. on its approximately $94.2 million IPO on the Nasdaq Global Select Market. The offering comprises 5,888,000 shares of common stock at a public offering price of $16.00 and is expected to close on February 14, subject to customary closing conditions.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products